In humans, a muscular dystrophy-dystroglycanopathy phenotype [MDDGA11, MIM:615181] including hydrocephalus has recently been associated with mutations in B3GALNT2 [30, 31]. The gene discussed is B3GALNT2; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.